Open access
55
Views
4
CrossRef citations to date
0
Altmetric
Review
Targeted treatments in advanced renal cell carcinoma: focus on axitinib
Elena VerzoniDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
, Paolo GrassiDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
, Isabella TestaDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
, Roberto IacovelliDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
, Pamela BiondaniDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
, Enrico GaranziniDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
, Filippo De BraudDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
& Giuseppe ProcopioDepartment of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyCorrespondence[email protected]
show all
Pages 107-116
|
Published online: 27 Mar 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.